NS
The startup develops stem cell therapeutics utilizing primed stem cells and their exosomes, employing single-cell analysis for precise gene editing. This approach aims to provide effective treatments for incurable diseases by targeting and correcting the underlying genetic causes.
Incheon, South Korea
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops stem cell therapeutics utilizing primed stem cells and their exosomes, employing single-cell analysis for precise gene editing. This approach aims to provide effective treatments for incurable diseases by targeting and correcting the underlying genetic causes.